Femoral artery infection associated with a percutaneous arterial suture device

VASA ◽  
2004 ◽  
Vol 33 (2) ◽  
pp. 83-85 ◽  
Author(s):  
Tiesenhausen ◽  
Tomka ◽  
Allmayer ◽  
Baumann ◽  
Hessinger ◽  
...  

This is a case report of a femoral artery infection with fatal outcome after using a percutaneous suture mediated closure device: A 77-year old patient underwent diagnostic angiography of his thoracic and abdominal aortic aneurysm, the puncture site was closed with the Perclose® system. He developed a staphylococcal femoral artery infection with groin abscess, requiring surgical intervention with debridement and removal of the Perclose® suture. After stent graft exclusion of the thoracic and abdominal aortic aneurysm a staphylococcal sepsis occurred and the patient died of aneurysm rupture months later despite long term antibiotic therapy. Since the use of the Perclose® device carries an increased risk of femoral artery infection with septic endarteritis and bacteremia, it should not be used in routine diagnostic angiography.

2021 ◽  
Vol 108 (Supplement_7) ◽  
Author(s):  
Ayman Badawy ◽  
Weronika Stupalkowska ◽  
Arindam Chaudhuri

Abstract Aim Though contraindicated in some respiratory laboratories due to a perceived increased risk of aneurysm rupture, pulmonary function tests (PFT) and cardiopulmonary exercise tests (CPET) are used commonly in preoperative assessment of patients with abdominal aortic aneurysm (AAA) considered for elective repair. We examine whether preoperative PFT/CPET are associated with increased AAA rupture risk. Methods A retrospective analysis of a prospective database of patients with AAA ≥50mm who had PFT/CPET/both as part of their preoperative assessment from November 2012 to December 2020 in a single vascular hub before elective AAA repair (open/endovascular). Patients with AAA <50mm, or those who did not have PFT/CPET preoperatively were excluded from analysis. Baseline demographics, AAA size, type of repair, time from PFT/CPET to repair, rupture rate and 30-day post-operative mortality are presented. Results A total of 410 patients (mean age 74 ± 8 years, 361 (88%) male) were included in the analysis. The mean AAA size was 63 ±11mm. 350 (85%) patients underwent endovascular repair. 220 (53%) patients had PFT, 69 (17%) had CPET and the remaining 121 (30%) had both PFT/CPET preoperatively. The median time from PFT/CPET to repair was 36 days (IQR 48 days), with no preoperative AAA rupture in this cohort. 30-day post-operative mortality was 3%. Conclusions This study strongly suggests that PFT and CPET are not associated with increased risk of AAA rupture and are therefore safe for assessing respiratory function in patients considered for AAA repair without adding to pre-operative rupture risk.


2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Enrique Gallego-Colon ◽  
Chaim Yosefy ◽  
Evgenia Cherniavsky ◽  
Azriel Osherov ◽  
Vladimir Khalameizer ◽  
...  

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Enrique Gallego-Colon ◽  
Chaim Yosefy ◽  
Evgenia Cherniavsky ◽  
Azriel Osherov ◽  
Vladimir Khalameizer ◽  
...  

Abstract Background Abdominal aortic aneurysm (AAA) is an asymptomatic condition characterized by progressive dilatation of the aorta. The purpose of this study is to identify important 2D-TTE aortic indices associated with AAA as predictive tools for undiagnosed AAA. Methods In this retrospective study, we evaluated the size of the ascending aorta in patients without known valvular diseases or hemodynamic compromise as predictive tool for undiagnosed AAA. We studied the tubular ascending aorta of 170 patients by 2-dimensional transthoracic echocardiography (2D-TTE). Patients were further divided into two groups, 70 patients with AAA and 100 patients without AAA with normal imaging results. Results Dilatation of tubular ascending aorta was measured in patients with AAA compared to the group with absent AAA (37.5 ± 4.8 mm vs. 31.2 ± 3.6 mm, p < 0.001, respectively) and confirmed by computed tomographic (CT) (35.6 ± 5.1 mm vs. 30.8 ± 3.7 mm, p < 0.001, respectively). An increase in tubular ascending aorta size was associated with the presence of AAA by both 2D-TTE and CT (r = 0.40, p < 0.001 and r = 0.37, p < 0.001, respectively). The tubular ascending aorta (D diameter) size of ≥33 mm or ≥ 19 mm/m2 presented with 2–4 times more risk of AAA presence (OR 4.68, CI 2.18–10.25, p = 0.001 or OR 2.63, CI 1.21–5.62, p = 0.02, respectively). In addition, multiple logistic regression analysis identified tubular ascending aorta (OR 1.46, p < 0.001), age (OR 1.09, p = 0.013), gender (OR 0.12, p = 0.002), and LVESD (OR 1.24, p = 0.009) as independent risk factors of AAA presence. Conclusions An increased tubular ascending aortic diameter, measured by 2D-TTE, is associated with the presence of AAA. Routine 2D-TTE screening for silent AAA by means of ascending aorta analysis, may appear useful especially in older patients with a dilated tubular ascending aorta (≥33 mm).


BMC Medicine ◽  
2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Olga E. Titova ◽  
John A. Baron ◽  
Karl Michaëlsson ◽  
Susanna C. Larsson

Abstract Background Cigarette smoking is a well-known risk factor for cardiovascular disease (CVD), but whether smokeless tobacco such as snuff is associated with the risk of CVD is still unclear. We investigated the association of the use of Swedish oral moist snuff (snus) with a broad range of CVDs and CVD mortality. Methods We used data from a population-based cohort of 41,162 Swedish adults with a mean baseline age of 70 (56–94) years who completed questionnaires regarding snus use and other lifestyle habits and health characteristics. Participants were followed up for incident cardiovascular outcomes and death over 8 years through linkage to the Swedish National Patient and Death Registers. Hazard ratios (HR) were estimated by Cox proportional hazards regression. We conducted analyses among all subjects as well as among never smokers to reduce residual confounding from smoking. Results After adjustment for smoking and other confounders, snus use was not associated with myocardial infarction, heart failure, atrial fibrillation, aortic valve stenosis, abdominal aortic aneurysm, stroke, or CVD mortality. However, in never smokers, snus use was associated with a statistically significant increased risk of total and ischemic stroke (HRs [95% confidence intervals] = 1.52 [1.01–2.30] and 1.63 [1.05–2.54], respectively) and non-significantly positively associated with some other CVDs. Conclusions In this middle-aged and elderly Swedish population, current Swedish snus use was not associated with the risk of major heart and valvular diseases, abdominal aortic aneurysm, or CVD mortality in the entire study population, but was linked to an increased risk of stroke in never smokers.


2013 ◽  
Vol 47 (7) ◽  
pp. 524-531 ◽  
Author(s):  
Jochen Schuld ◽  
Otto Kollmar ◽  
Simone Schuld ◽  
Kai Schommer ◽  
Sven Richter

Sign in / Sign up

Export Citation Format

Share Document